Interestingly, inactivation of chromatin modifier p300, a homolog of the histone acetyltransferase CREBBP, has been associated with deregulation of MYC transcription in lung cancer cell lines, and loss of MYC expression in the context of CREBBP and EP300 loss is synthetically lethal20,21. This evidence concerns the gene CREBBP and lung cancer.